Margonil en es it fr

Margonil Brand names, Margonil Analogs

Margonil Brand Names Mixture

  • No information avaliable

Margonil Chemical_Formula


Margonil RX_link

No information avaliable

Margonil fda sheet

Margonil msds (material safety sheet)

Margonil Synthesis Reference

No information avaliable

Margonil Molecular Weight

309.469 g/mol

Margonil Melting Point

< 25 oC

Margonil H2O Solubility

Soluble as HCl salt

Margonil State


Margonil LogP


Margonil Dosage Forms

Tablets (oral, 1 mg)

Margonil Indication

Used for the symptomatic treatment of parkinsonism.

Margonil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Margonil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Margonil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Margonil Patient Information

Margonil Organisms Affected

Humans and other mammals